MM
CRL icon

MQS Management’s Charles River Laboratories CRL Stock Holding History

MQS Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,561
Closed -$322K – 478
2024
Q2 		$322K Buy
+1,561
New +$354K 0.2% 225
2023
Q3 		– Sell
-1,892
Closed -$398K – 457
2023
Q2 		$398K Buy
+1,892
New +$376K 0.27% 136
2022
Q3 		– Sell
-2,783
Closed -$595K – 446
2022
Q2 		$595K Buy
2,783
+1,893
+213% +$463K 0.41% 64
2022
Q1 		$253K Sell
890
-329
-27% -$101K 0.21% 244
2021
Q4 		$459K Buy
+1,219
New +$474K 0.74% 33

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

MQS Management's CRL Position: Q3 2024 in Review

MQS Management sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 1,561 shares — an estimated $322K sold.

MQS Management first reported a position in CRL in Q4 2021 and held it in 5 quarters. The position peaked at $595K in Q2 2022. 627 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • MQS Management reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • MQS Management sold 1,561 Charles River Laboratories shares in Q3 2024, an estimated $322K.
  • MQS Management first reported a position in Charles River Laboratories in Q4 2021 and held it in 5 quarters.
  • MQS Management's Charles River Laboratories position peaked at $595K in Q2 2022.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on MQS Management's 13F filing for Q3 2024, filed 5 Nov 2024.